We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Developing Novel Ear Infection Treatments

Research team engineers antibiotic gel for treating middle ear infections.
News

ProNAi Licenses Inhibitor from CRT

ProNAi Therapeutics, Inc. has licensed an inhibitor of Checkpoint kinase 1 from CRT Pioneer Fund LP.
News

Galapagos Completes Regulatory Consultations to Progress Filgotinib to Phase 3 Study

DIVERSITY Phase 3 study in Crohn’s disease.
News

Amgen's Kyprolis Fails Phase III Trial

Amgen's Kyprolis has failed its 54 week Clarion Phase 3 trial which was evaluating its effectiveness in multiple myeloma patients.
News

New Weapon Against Hard-to-Treat Bacterial Infections

Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
News

Washing Clothes Releases Microplastic Particles

Research suggests that over 700,000 microfibres could be released in waste water with every run of a domestic washing machine.
News

Regulatory RNA Essential to DNA Damage Response

Researchers discover a tumour suppressor is stabilized by an RNA molecule, which helps cells respond to DNA damage.
News

Immunic Acquires 4SC’S Immunology Portfolio

Company has acquired two promising drug development programs with validated targets known to be relevant in various immune and autoimmune diseases.
News

Vaccine Against Common Cold Achievable

Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
News

Tapping Evolution to Improve Biotech Products

Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Advertisement